» Articles » PMID: 35584832

Sickle Cell Disease: an Update

Overview
Journal Clin Med (Lond)
Specialty General Medicine
Date 2022 May 18
PMID 35584832
Authors
Affiliations
Soon will be listed here.
Abstract

Sickle cell disease is a common inherited disorder that is characterised by chronic haemolysis and vaso-occlusive episodes, resulting in severe pain and end-organ damage. The most frequent acute manifestation of sickle cell disease is a painful vaso-occlusive crisis, which can, in some cases, develop into a sickle chest crisis: a life-threatening complication of sickle cell disease that requires early recognition and prompt intervention to prevent progressive respiratory failure. In addition to the acute complications, patients with sickle cell disease are also at risk of a number of chronic complications that require multidisciplinary specialist input.

Citing Articles

Epidemiological profile trends and cost of pediatric sickle cell disease in Brazil from 2008 to 2022.

Telles L, Melo P, Dornelas L, Lech G, Sampaio N, Gerk A J Pediatr (Rio J). 2024; 101(1):110-116.

PMID: 39251065 PMC: 11763541. DOI: 10.1016/j.jped.2024.07.010.

References
1.
Vichinsky E, Neumayr L, Earles A, Williams R, Lennette E, Dean D . Causes and outcomes of the acute chest syndrome in sickle cell disease. National Acute Chest Syndrome Study Group. N Engl J Med. 2000; 342(25):1855-65. DOI: 10.1056/NEJM200006223422502. View

2.
Platt O, Orkin S, Dover G, Beardsley G, Miller B, Nathan D . Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest. 1984; 74(2):652-6. PMC: 370519. DOI: 10.1172/JCI111464. View

3.
Qureshi A, Kaya B, Pancham S, Keenan R, Anderson J, Akanni M . Guidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British Society for Haematology Guideline. Br J Haematol. 2018; 181(4):460-475. DOI: 10.1111/bjh.15235. View

4.
Haywood Jr C, Lanzkron S, Bediako S, Strouse J, Haythornthwaite J, Carroll C . Perceived discrimination, patient trust, and adherence to medical recommendations among persons with sickle cell disease. J Gen Intern Med. 2014; 29(12):1657-62. PMC: 4242876. DOI: 10.1007/s11606-014-2986-7. View

5.
Darbari D, Sheehan V, Ballas S . The vaso-occlusive pain crisis in sickle cell disease: Definition, pathophysiology, and management. Eur J Haematol. 2020; 105(3):237-246. DOI: 10.1111/ejh.13430. View